Invus Public Equities, L.P. Glycomimetics Inc (GLYC) insider trading activity

Invus Public Equities, L.P. is > 10% Shareholder of GLYCOMIMETICS INC. Currently has a direct ownership of 8.59 Million shares of GLYC, which is worth approximately $2.83 Million. The most recent transaction as insider was on Feb 24, 2023, when has been sold 100,000 shares (Common Stock) at a price of $1.7 per share, resulting in proceeds of $170,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.59M

0% 3M change

0% 12M change

Total Value Held $2.83 Million

Invus Public Equities, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 24 2023	BUY Open market or private purchase	$170,000 $1.7 p/Share	100,000 Added 1.15%	8,589,064 Common Stock
Feb 23 2023	BUY Open market or private purchase	$350,000 $1.75 p/Share	200,000 Added 2.3%	8,489,064 Common Stock
Feb 22 2023	BUY Open market or private purchase	$268,500 $1.79 p/Share	150,000 Added 1.78%	8,289,064 Common Stock
Feb 21 2023	BUY Open market or private purchase	$92,500 $1.85 p/Share	50,000 Added 0.61%	8,139,064 Common Stock
Feb 17 2023	BUY Open market or private purchase	$340,000 $1.7 p/Share	200,000 Added 2.41%	8,089,064 Common Stock
Feb 16 2023	BUY Open market or private purchase	$529,646 $1.68 p/Share	315,266 Added 3.84%	7,889,064 Common Stock
Feb 15 2023	BUY Open market or private purchase	$2,160,000 $2.16 p/Share	1,000,000 Added 11.66%	7,573,798 Common Stock

Feb 09 2023	BUY Open market or private purchase	$37,101 $3.24 p/Share	11,451 Added 0.17%	6,573,798 Common Stock

Also insider at

SEER

Seer, Inc. Healthcare

> 10% Shareholder

GBIO

Generation Bio Co. Healthcare

> 10% Shareholder

LXRX

LEXICON PHARMACEUTICALS, INC. Healthcare

Director

SRRK

Scholar Rock Holding Corp Healthcare

OMGA

Omega Therapeutics, Inc. Healthcare

> 10% Shareholder

SQZ

SQZ Biotechnologies Co Healthcare

> 10% Shareholder

IPE